{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:45:29Z","timestamp":1784742329444,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,11,23]],"date-time":"2007-11-23T00:00:00Z","timestamp":1195776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10067-007-0786-8","type":"journal-article","created":{"date-parts":[[2007,11,22]],"date-time":"2007-11-22T08:16:11Z","timestamp":1195719371000},"page":"373-375","source":"Crossref","is-referenced-by-count":29,"title":["Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease"],"prefix":"10.1007","volume":"27","author":[{"given":"H.","family":"Direskeneli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ergun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Hamuryudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Eksioglu-Demiralp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,23]]},"reference":[{"key":"786_CR1","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.60.11.996","volume":"82","author":"H Direskeneli","year":"2001","unstructured":"Direskeneli H (2001) Review: Beh\u00e7et's disease: infectious etiology, new auto-antigens and HLA-B51. Ann Rheum Dis 82:996\u20131002","journal-title":"Ann Rheum Dis"},{"key":"786_CR2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archderm.1982.01650200004003","volume":"118","author":"T Saylan","year":"1982","unstructured":"Saylan T, Saltik I (1982) Thalidomide in the treatment of Behcet's syndrome. Arch Dermatol 118:536","journal-title":"Arch Dermatol"},{"key":"786_CR3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02054255","volume":"5","author":"MH Hamza","year":"1986","unstructured":"Hamza MH (1986) Treatment of Behcet's disease with thalidomide. Clin Rheumatol 5:365\u2013371","journal-title":"Clin Rheumatol"},{"key":"786_CR4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archinte.1986.00360170074012","volume":"146","author":"JL Jorizzo","year":"1986","unstructured":"Jorizzo JL, Schmalstieg FC, Solomon AR Jr, Cavallo T, Taylor RS 3rd, Rudloff HB, Schmalstieg EJ, Daniels JC (1986) Thalidomide effects in Behcet's syndrome and pustular vasculitis. Arch Intern Med 146:878\u2013881","journal-title":"Arch Intern Med"},{"key":"786_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","volume":"128","author":"V Hamuryudan","year":"1998","unstructured":"Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et's syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:443\u2013450","journal-title":"Ann Intern Med"},{"issue":"Suppl 5","key":"786_CR6","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1053\/j.seminoncol.2005.06.018","volume":"32","author":"R Knight","year":"2005","unstructured":"Knight R (2005) IMiDs: a novel class of immunomodulators. Semin Oncol 32(Suppl 5):S24\u2013S30","journal-title":"Semin Oncol"},{"key":"786_CR7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9343(99)00408-8","volume":"108","author":"L Calabrese","year":"2000","unstructured":"Calabrese L, Fleischer AB (2000) Thalidomide: current and potential clinical applications. AM J Med 108:487\u2013495","journal-title":"AM J Med"},{"key":"786_CR8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"EP Sampaio","year":"1991","unstructured":"Sampaio EP, Sarno EN, Galilly R et al (1991) Thalidomide selectively inhibits tumor necrosis factor \u03b1 production by stimulated human monocyte. J Exp Med 173:699\u2013703","journal-title":"J Exp Med"},{"key":"786_CR9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","volume":"99","author":"SM McHugh","year":"1995","unstructured":"McHugh SM, Rifkin IR, Deighton J et al (1995) The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 99:160\u2013167","journal-title":"Clin Exp Immunol"},{"key":"786_CR10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","volume":"163","author":"LG Corral","year":"1999","unstructured":"Corral LG, Haslett PAJ, Muller GW, Chen R, Wong LM, Ocampo CJ et al (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-\u03b1. J Immunol 163:380\u2013386","journal-title":"J Immunol"},{"key":"786_CR11","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et's Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et's Disease (1990) Criteria for diagnosis of Beh\u00e7et's disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"786_CR12","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","volume":"177","author":"AL Moriera","year":"1993","unstructured":"Moriera AL, Sampaio EP, Zmuidzinas A et al (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor-\u03b1 by enhancing m-RNA degradation. J Exp Med 177:1675\u20131680","journal-title":"J Exp Med"},{"key":"786_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0162-3109(95)00050-X","volume":"131","author":"H Geitz","year":"1996","unstructured":"Geitz H, Handt S, Zwingerberger K (1996) Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacology 131:213\u2013221","journal-title":"Immunopharmacology"},{"key":"786_CR14","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.168.6.2644","volume":"168","author":"S Majumdar","year":"2002","unstructured":"Majumdar S, Lamothe B, Aggarwal BB (2002) Thalidomide suppresses NF-\u03baB activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides or phorbol ester. J Immunol 168:2644\u20132651","journal-title":"J Immunol"},{"key":"786_CR15","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/art.21145","volume":"52","author":"M Todaro","year":"2005","unstructured":"Todaro M, Zerilli M, Triolo G et al (2005) NF-\u03baB protects Behcet's disease T cells against CD95-induced apoptosis up-regulating anti-apoptotic proteins. Arthritis Rheum 52:2179\u20132191","journal-title":"Arthritis Rheum"},{"key":"786_CR16","first-page":"175","volume":"296","author":"ES Lee","year":"2004","unstructured":"Lee ES, Kim YA, Kwon HJ, Bang D, Lee S, Sohn S (2004) Thalidomide upregulates macrophage inflammatory protein-1\u03b1 in a herpes simplex virus-induced Behcet's disease-like animal model. Arch Dermatol Res 296:175\u2013181","journal-title":"Arch Dermatol Res"},{"key":"786_CR17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1086\/498216","volume":"192","author":"PA Haslett","year":"2005","unstructured":"Haslett PA, Roche P, Butlin CR et al (2005) Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation. J Infect Dis 192:2045\u20132053","journal-title":"J Infect Dis"},{"key":"786_CR18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-4632.2004.02274.x","volume":"43","author":"I Estrada-G","year":"2004","unstructured":"Estrada G I, Garibay-Escobar A, Nunez-Vazquez A et al (2004) Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo. Int J Dermatol 43:893\u2013897","journal-title":"Int J Dermatol"},{"issue":"Suppl 34","key":"786_CR19","first-page":"S59","volume":"22","author":"A Kibaroglu","year":"2004","unstructured":"Kibaroglu A, Eksioglu-Demiralp E, Akoglu T, Direskeneli H (2004) T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behcet's disease. Clin Exp Rheumatol 22(Suppl 34):S59\u2013S63","journal-title":"Clin Exp Rheumatol"},{"key":"786_CR20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.01069.x","volume":"118","author":"J Freysdottir","year":"1999","unstructured":"Freysdottir J, Lau S, Fortune F (1999) Gamma\u2013delta T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 118:451\u2013457","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0786-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0786-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0786-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T22:02:12Z","timestamp":1684101732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0786-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,23]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0786-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,23]]}}}